New ALS therapy extends survival and reverses some neuromuscular damage in animals innovationtoronto.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from innovationtoronto.com Daily Mail and Mail on Sunday newspapers.
Anesthesiologist Michael S. Avidan, MBBCh, reproductive biologist Sarah K. England, PhD, and neurologist Timothy Miller, MD, PhD, all of Washington University School of Medicine in St. Louis, have been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine in the United States.
The drug, tofersen, was developed specifically for patients with SOD1-ALS, a rare form of the disease that occurs because of mutation in the SOD1 gene.
A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). Called tofersen, the drug developed by Biogen Inc. and based in part on research conducted at Washington University School of Medicine in St. Louis slows the progression of the deadly, paralyzing disease.
Miller receives Rainwater Prize for Brain Research miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.